# Levemir

NDC: 0169-3687
Generic name: insulin detemir
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20060327
Marketing ended: 20260831
FDA application: BLA021536

## Active ingredients

- INSULIN DETEMIR: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-3687"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-3687
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d38d65c1-25bf-401d-9c7e-a2c3222da8af